Mitochondrial DNA (mt-DNA) disorders and abnormal regulation of nuclearderived proteins devoted to the cross-talk between the two cellular genomes have recently interested researchers in the field of neuromuscular diseases. We have identified, isolated and sequenced a new gene, augmenter of liver regeneration (ALR) that stimulates in vivo hepatocyte proliferation and up-regulates mt-DNA expression and ATP production. ALR protein (Alrp) is mainly located, in rat, in the mitochondrial inter-membrane space and its mRNA is particularly abundant in brain, muscle, testis and liver, tissues whose activity is mostly dependent on mitochondrial metabolism. Studies on rat Alrp sequence revealed the presence of homologous amino-acid sections into proteins derived from mouse, human, Drosophyla, plants and even DNA viruses. In this article, we evaluated ALR expression in normal human muscular tissues, both as protein and as mRNA. The data, obtained by molecular biology, immunohistochemistry and electron microscopy, demonstrated that: (i) Alrp and ALR mRNA are present in human muscular tissue; (ii) Alrp is particularly expressed in muscular fibres rich in mitochondria; (iii) Alrp is localized in the mitochondrial inter-membrane space or associated to mitochondrial cristae; and (iv) in subjects younger then 35 years of age, ALR mRNA expression is different between male and female subjects. In conclusion, the present data set Alrp, as a factor associated with mitochondria also in human tissue, call for future studies aimed at establishing Alrp as an important factor involved in the molecular events that trigger neuromuscular diseases.
The contractile activity of skeletal muscular fibres depends, predominantly, on the energy supplied by mitochondrial oxidative phosphorylation, a biological process that involves several enzymes and proteins, 13 of which are encoded by mitochondrial DNA (mt-DNA), and all the rest by nuclear DNA (n-DNA). Mitochondrial phosphorylation-associated biochemical events require then an efficient cross-talk between mt-and n-genome that is facilitated by several nuclear encoded proteins (Garstka et al. 1994) . Among them, mitochondrial transcription factor A (mt-TFA) is one of the most important (Parisi & Clayton 1991; Shadel & Clayton 1993; Larsson et al. 1994 Larsson et al. , 1996 .
Our group identified and isolated a protein from rat liver that is able to augment, in vivo in rat, hepatocyte proliferative spur consequent to 40% partial hepatectomy. This factor, termed augmenter of liver regeneration (ALR) Hagiya et al. 1994) , belongs to the ancestral and well-conserved ERV1 ⁄ ALR protein family and it is present in all eukaryotic cells Giorda et al. 1996) , in yeast (Lisowsky 1994) , fruit fly (Klebes et al. 2005 ) and even viruses (Senkevich et al. 2000) . These proteins, highly divergent in their amino terminal domain, show a strong homology in their well-conserved, carboxy terminal domain (Hofhaus et al. 1999) , where a CXXC motif indispensable for the sulphydryl oxidase enzyme activity of this protein family is present .
Of particular interest is the 40% homology of ALR protein (Alrp) with saccharomyces cerevisiae essential for respiration and viability 1 (scErv1) (Lisowsky et al. 1995; Polimeno et al. 1999) , a factor present in yeast and known to be important for the biogenesis of mitochondria and the viability of the cell (Lisowsky 1994) . It is already well known that Alrp activity and mitochondrial metabolism are strictly related: (i) Alrp is predominantly localized in the mitochondrial inter-membrane space (Hofhaus et al. 1999; Lange et al. 2001) , (ii) Alrp and its homologue scErv1 are proteins necessary for mitochondrial biogenesis (Hofhaus et al. 1999) , characterized by direct interaction with cytochrome c (Allen et al. 2005; Dabir et al. 2007; Koehler & Tienson 2008) , and an essential function for the maturation of cytosolic Fe ⁄ S proteins (Lange et al. 2001) , and (iii) complementation studies have demonstrated that the C-terminal part of rat Alrp and scErv1 can functionally be interchanged, even if the two organisms are phylogenetically distant (Lisowsky et al. 1995) .
Alrp mRNA in rat has been identified in all tissues in relatively low quantities with the exception of testis, muscle, nervous system and liver Giorda et al.1996) , where it has been detected in large quantity, suggesting that Alrp may play a fundamental role for the proper functioning of these organs.
Alrp, when injected in intact rats, produces a burst of mitochondrial metabolism and a significant increase of the expression of mitochondrial genes and of nuclear-encoded mt-TFA. This latter event is associated with an enhanced cytochrome content and oxidative phosphorylation capacity of liver mitochondria, exhibiting a significantly higher rate of oxygen consumption and ATP production (Polimeno et al. 2000) . An increased ALR mRNA and serum protein expression have been detected in regenerating liver after 70% partial hepatectomy in rats (Yang et al. 1997; Gandhi et al. 1999) , when an increased energetic demand is required for the regenerating tissue (Onoue et al. 1996; Guerrieri et al. 1999) .
Despite this knowledge, few reports investigate the presence of Alrp in mammalian tissues and no data are available on human tissues. Tury et al. (2005) report in their study the presence of Alrp in rat brain and Thasler et al. (2005) documented the presence of Alrp in human hepatocellular carcinoma.
We therefore surmised that it would be of interest to study ALR expression in human skeletal muscular tissue, particularly rich in mitochondria.
In this article, we report the first results on the characterization and localization of ALR in human muscular tissue samples taken from patients hospitalized in the Orthopedic Unit of the Policlinico of Bari, evaluating:
• type I and type II muscle fibres, identified according to the presence of mitochondrial enzymes (ATPase and NADH-tetrazolium reductase), detected by enzymatic techniques;
• Alrp presence, by immunohistochemistry, using a specific polyclonal antibody;
• ALR mRNA expression, by molecular biology technique; • Alrp subcellular localization by electron microscopy.
Materials and methods

Patients
In Table 1 , data on the source of tissue samples are reported. One hundred twenty patients, 60 of each gender, from 18 to 85 years of age, without any muscular or neurodegenerative disease, were enrolled. As reported, the patients were divided into three groups of 20 subjects for each gender, according to their age. Tissue samples were taken only from the inferior or superior limb of the patients, who attended the Orthopedic Unit of the Medical School of University of Bari for bone fracture and who gave their informed consent for such a study. There was no statistically significant difference on the source of the samples among the female and male patients from the same age group (Female inferior limb: 87.5% for group I vs. 95.65% and 95.24% for group II and III respectively; Male inferior limb: 90.9% for group I vs. 94.0% and 96.1% for groups II and III respectively; Female superior limb: 12.5% for group I vs. 4.35% and 4.76% for groups II and III respectively; Male superior limb: 9.1% for group I vs. 6.0% and 3.9% for groups II and III respectively). Collectively, all tissue samples, 92.8% for female groups and 93.7% for male groups derived from the superior limbs. Every tissue was observed by a pathologist, by basic histological, histochemical and ultrastructural procedures, in order to verify the absence of any muscular disease and was processed for:
• mitochondrial enzyme (NADH-tetrazolium reductase and ATPase) determination;
• Alrp immunogold labelling for electron microscopy.
Alrp immunohistochemical detection and mitochondrial enzyme determinations were performed on serial tissue sections.
ALR mRNA expression
Total RNA extraction, RNA preparation and first-strand cDNA synthesis. Tissue samples were taken and kept in RNA Later (Qiagen GmbH, Germany) in order to preserve mRNA. Total RNA was extracted from tissue using the RNeasy Mini Kit (Qiagen GmbH) according to the manufacturer's instructions. Final mRNA concentrations were estimated by ultraviolet absorbance at 260 nm. Aliquots of total mRNA (1 lg) were reverse-transcribed using random hexamers and the TaqMan Reverse Transcription Reagents (Applied Biosystems, Monza, Italy) with 3.125 U ⁄ ll of MultiScribe Reverse Transcriptase in a final volume of 50 ll.
ALR mRNA quantitative real-time PCR. Real-time PCR was performed in 96-well plates on the ABI Prism 7900HT Sequence Detection System (Applied Biosystems). Data collection and analysis were performed using the machine software. Two-step reverse transcription-PCR was performed using first-strand cDNA with a final concentration of 1· TaqMan gene expression Assay (ALR and 18S) and 1· TaqMan Universal PCR Master Mix. The final reaction volume was 50 ll. Each sample was analysed in triplicate and all experiments were repeated twice. A non-template control (Rnasefree water) was included on every plate. The thermal cycler conditions were 2 min hold at 50°C, 10 min hold at 95°C, followed by 40 cycles of 15 s at 95°and 1 min at 60°C.
In the first instance, a standard curve and a validation experiment were performed for each primer ⁄ probe set. A series of six serial dilutions (20 to 0.1 ng ⁄ ll) of liver tissue cDNA were used as a template for each primer ⁄ probe set.
Standard curves were generated by plotting the threshold cycle (TC) number values against the log of the amount of input cDNA. Threshold cycle is the PCR cycle at which an increase in reported fluorescence above the baseline level is first detected. The average and SD of amount of target gene expressed were normalized to an endogenous reference and is relative to a calibrator and the relative quantification for each sample was plotted in bar chart using Microsoft Excel software. The endogenous reference used in all of the experiments reported here was GAPDH. A normal liver tissue was used as calibrator in all of the experiments.
Primers and probes for quantitative real-time reverse transcription-PCR. PCR primers and fluorogenic probes for target gene and endogenous controls were purchased as PreDeveloped TaqMan Assay for 18S gene and TaqMan Gene Expression Assay for ALR gene (Applied Biosystems, Foster City, CA, USA) with the following sequences: ALR for: CTC GAG TGT CCT TCA GCCA, ALR rev: GCT TCC GGT TCA CTT CAT TGTG, ALR probe: AAG GCG GCA CAG CCA. The assays were supplied as a 20· mix of PCR primers and TaqMan Minor Groove Binder 6-FAM dye labelled probes with a non-fluorescent quencher at the 3¢-end of the probe.
Mitochondrial enzymes determination
Muscle biopsies were taken and immediately frozen in isopentane in the vapours of liquid nitrogen. The specimens were then sectioned with a freezing microtome, Leika CM 1900 (Leika Microsystems, Milan, Italy) obtaining serial slides which were fixed in acetone before immunohistochemical procedures.
NADH-tetrazolium reductase. Specimens of human frozen muscle slides (10 lm) were incubated in a solution containing NitroBlue Tetrazolium (Sigma-Aldrich, Milan, Italy) in Tris Buffer pH 7.4 and NADH for 30¢ at room temperature. After three washes in phosphate-buffered saline (PBS) for 5¢ sections were gradually dehydrated in alcohol, then clarified and mounted. Fibres were considered positive when a blue colour developed.
ATPase. Human frozen muscle sections (10 lm) were incubated at 37°C for 10¢ respectively in Acetate Buffer pH 4.3, Acetate Buffer pH 4.7 and glycine buffer ⁄ NaOH pH 10.4. After a wash of 30¢¢ in a solution of calcium chloride, slides were incubated at 37°C for 30¢ in a buffer solution containing ATP. Sections were then washed three times for 2¢ with a solution of calcium chloride and twice for 2¢ with a solution of cobalt chloride and four times 20¢¢ in distilled water. After washes, slides were then developed 30¢¢ in a solution of ammonium sulphate and then washed 5¢ in distilled water. Sections were then counterstained with Mayer's haematoxylin for 5¢ and washed in tap water for 5¢. Sections were then gradually dehydrated in alcohol, clarified and mounted. Fibres were considered positive when a dark brown colour developed.
Alrp immunohistochemical evaluation
Alrp presence in tissue sections was detected using a specific polyclonal antibody anti-ALR (MultiBind GmbH, Koln, Germany), (Thasler et al. 2005) . Six-lm-thick human frozen muscle slides were fixed in Acetone for 10¢. Endogenous peroxidase was blocked in H 2 O 2 ⁄ methanol 1:10 v ⁄ v for 7¢ at room temperature. After three washes in PBS (pH 7.4) (Sigma Aldrich), sections were incubated in a solution of 3% Goat Serum (Sigma Aldrich) in PBS (blocking solution) for 30¢ at room temperature. Sections were then incubated in blocking solution containing the rabbit polyclonal anti-ALR antibody diluted 1:200 at 4°C overnight. Sections were then washed three times for 5¢ in PBS and incubated 1 h at room temperature with the EnVision System Labelled Polymer HRP anti-rabbit (Dako, Carpinteria, CA, USA). Sections were then washed three times for 5¢ in PBS and incubated in a solution containing 3-amino,9-ethyl-carbazole chromogen (AEC) (Vector Labs, Burlingame, CA, USA) that provides the red chromogen deposition at the reaction sites on tissue. After three washes of 5¢ in PBS, slides were mounted. Slides were considered positive for this reaction when a red colour was developed. Appropriate controls to verify the specificity of Alrp identification were done incubating the tissue samples only in the presence of secondary Ab or using the preimmune rabbit serum.
Alrp immunogold labelling
The immunolocalization of Alrp was performed on 6-lm muscle tissue samples from patients aged 35-74 years, and not affected by muscular or neurodegenerative disease.
The muscular biopsy was fixed in 2.5% glutaraldehyde in PBS (pH 7.4), dehydrated in alcohol and embedded in epossidic resin. Immunogold labelling of ultra-thin sections was conducted using anti-Rabbit IgG Conjugate, 10 nm (Sigma).
Thin sections were incubated in blocking solution consisting of phosphate buffer pH 7.4 plus 2% bovine serum albumin (BSA) for 15 min, and then incubated with 2% normal goat serum in PBS plus 2% BSA for 15 min. Samples were then incubated with primary anti-sera diluted 1:350 in PBS for 2 h, washed and incubated for 1 h with 10 nm gold conjugated rabbit diluted 1:20 in PBS. Grids were washed with ddH 2 O, and stained with uranyl acetate and lead citrate and observed with a TEM Morgagni 268.
Statistical analysis
The results obtained were expressed as mean ± standard deviation. Statistical comparison among groups was determined using analysis of variance test (anova). Where indicated, individual comparisons were performed using Student's t-test. Statistical significance was ascribed to the data when P < 0.05. Figure 1 reports ALR mRNA expression, considering male (hatched columns) and female (white columns) subjects separately. In each group, we considered three subgroups of 20 samples each, according to their age (18-35; 36-70, 71-85 years) . No difference of ALR mRNA levels was detected between the two genders in patients older than 35 years (groups II and III). On the contrary, a significant (P < 0.038) difference between the two genders was evidenced in patients aged between 18 and 35 years (group I). The subjects have been divided into three groups for each gender (female white columns, male hatched columns) according to their age. The data (mean ± SD) are typical of three separate experiments. Figure 3 Alrp immunolabelling detection by electron microscopy in normal skeletal muscle. The labelling is evident both in the mitochondrial inter-membrane space and on some mitochondrial cristae (arrows). Microphotography 44.000·.
Results
ALR mRNA expression
Alrp immunodetection and mitochondrial protein expression
Alrp electron microscopy detection
Ultrastructural description: immunolabelling with colloidal gold (10 nm) was performed in post embedding on normal (non-pathological) skeletal muscle. The labelling is evident both in the mitochondrial inter-membrane space and on some mitochondrial cristae. Sporadic localization of Alrp was detected in the acto-miosin structures. The other sarcoplasmatic and sarcolemmatic structures are not labelled. Microphotography 44.000· (Figure 3) .
Detail at stronger magnification of the previous microphotography. Localization in the mitochondrial inter-membrane space and on some mitochondrial cristae. Microphotography 71.000· (Figure 4 ).
Discussion
Alrp is a factor of special interest because, besides its involvement in mitochondrial biogenesis, it was shown to have a function in cytosolic iron sulphur cluster assembly and in the regulation of cellular development Hofhaus et al. 1999; Lange et al. 2001) .
It is known that the mRNA for ALR is expressed in large amounts in brain, muscle, liver and testis of mouse and rat Giorda et al. 1996) , whose activity is strictly related to mitochondria metabolism (Gauthier & Padykula 1966) .
In this article, we analysed and localized, for the first time, ALR in human skeletal muscular tissue. One hundred twenty subjects were enrolled, 60 males and 60 females, divided, each gender-group, into three subgroups of 20 subjects each according to their age (Table 1) .
The first finding is the demonstration of the presence of Alrp in different types of muscular fibres. In fact, the analysis of tissue slides immunostained for Alrp shows a panel consistent with that observed by the analysis of mitochondrial enzymes in serial samples from the same tissue. It is important to recall that human skeletal muscle fibres are divided, according to their metabolism, into two categories: slow-twitch or type I fibres, that show an oxidative metabolism, rich in mitochondria, greatly vascularized and fatigue-resistant and fast-twitch or type II fibres, that show a glycolytic metabolism and are involved in fast contraction movements and easily outwear. In spite of these differences, a workload or a prolonged training could lead fast fibres (type II) to change into slow type (type I); conversely, a decrease of the neuromuscular activity could cause a change from type I to type II fibres.
A different functional demand can also modulate the skeletal fibre phenotypes by activating different molecular pathways that control the genomic expression pattern. The different molecular patterns are of particular interest as they can be found in several human diseases, such as muscular dystrophy, metabolic disorders and muscular atrophy. Several neuromuscular diseases, myopathies, neuropathies and complex syndromes such as progressive external ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS), Pearson's syndrome and many others may be primarily considered as mitochondrial diseases (DiMauro et al. 1998; Bindoff 1999) . These diseases mainly affect the respiratory chain and the oxidative phosphorylation and thereby tissues from muscle, brain and nerves, as these tissues are highly dependent on oxidative metabolism and therefore highly vulnerable to a mitochondrial impairment.
On muscular tissue slides, it is possible to distinguish, by enzymatic evaluation of mitochondrial proteins such as ATPase and NADH tetrazolium reductase, the two categories of the muscular fibres. The possibility to detect Alrp and mitochondrial proteins in serial tissue slides gave us the opportunity to show that mitochondrial enzyme-positive fibres are also Alrp-positive, confirming the association of Alrp with the presence of mitochondria, particularly abundant in slow muscular fibres.
Furthermore, from our data comes out a significant difference of ALR mRNA expression between young subjects of both genders (Figure 1) . Also Alrp immunodetection, by Western blot analysis, evidenced lower level in cytosol of muscular tissues from young female as compared with young male patients (data not reported), confirming the mRNA Figure 4 Microphotography 71.000·. A stronger magnification of Alrp detection by electron microscopy is reported. Localization in the mitochondrial inter-membrane space and on some mitochondrial cristae (arrows). data ( Figure 1) . These results raise the question as to why there is such a significant difference in the expression of ALR mRNA in the muscle tissues in young people of different genders. We could assume that these two groups of subjects, presumably because of the different physical activity, or more likely, because of the different degrees of resistance to fatigue, may have different oxidative phosphorylation activities inside mitochondria and, consequently, also have different levels of nuclear factors controlling mt-DNA, such as Alrp (Polimeno et al. 2000) . Unfortunately, we could not collect muscular tissue from young male and female subjects professionally practising sports, which could elucidate whether the difference of ALR mRNA expression, herein reported (Figure 1) , depends on physical exercise or whether it is hormone-related, or genetically regulated. In this context, studies on the role of different hormonal profiles and neuromuscular control among the two genders have already been reported in the literature (Hurd et al. 2004; da Fonseca et al. 2006) .
The lower expression of ALR mRNA in young women, as reported by us (Figure 1 ), should not have been influenced by a gender-related difference in the morphological characteristics of the muscular tissues (type I and type II fibres). Indeed, data available in literature report, in humans, no differences in the oxidative enzyme activities, which mostly depend on glycolytic oxidative activity of type I fibres between young men and women (Jaworowski et al. 2002) , and in rats, a greater cross-sectional area of type I fibres in young female rats compared with young male ones (Fox et al. 2003) .
We believe also the data on the presence of Alrp in muscle tissues by electron microscopy to be important (Figures 3  and 4) . For the first time, the exact cellular distribution of Alrp in the human tissue has been reported. As a matter of fact, it has only been possible to associate Alrp to the mitochondrial inter-membrane space in the previous papers (Hofhaus et al. 1999; Lange et al. 2001) . Our present data definitely demonstrate the association of Alrp to the mitochondria and, in addition, identify that Alrp not only is present in the mitochondrial inter-membrane space (Hofhaus et al. 1999; Lange et al. 2001) , but also close to mitochondrial cristae, suggesting the close association of Alrp to different mitochondrial activities (Allen et al. 2005; Farrell & Thorpe 2005) .
In conclusion, all these data deliver a significant contribution to understanding the expression of Alrp in normal human tissue, defining a new reference for future studies on the involvement of this factor in human muscular or neuromuscular diseases, still to be characterized from a molecular point of view.
